Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.49
-0.07 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Viridian Therapeutics Market Cap

Viridian Therapeutics has a market cap or net worth of $1.10 billion as of April 25, 2025. Its market cap has increased by 4.01% in one year.

Market Cap
1.10B
Enterprise Value
405.58M
1-Year Change
4.01%
Ranking
Category
Stock Price
$13.49

Market Cap Chart

Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.10B, an increase of 3,070.16%. That is a compound annual growth rate of 37.48%.

History

DateMarket Cap% Change
Apr 24, 20251.10B-27.24%
Dec 31, 20241.52B32.59%
Dec 29, 20231.15B-2.59%
Dec 30, 20221.18B173.74%
Dec 31, 2021429.50M567.96%
Dec 31, 202064.30M320.26%
Dec 31, 201915.30M-83.62%
Dec 31, 201893.40M-59.86%
Dec 29, 2017232.70M6,363.89%
Dec 30, 20163.60M-55.00%
Dec 31, 20158.00M-16.67%
Dec 31, 20149.60M-72.33%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 743.12B
UnitedHealth Group 388.83B
Johnson & Johnson 380.15B
AbbVie 307.41B
Novo Nordisk 266.18B
Abbott Laboratories 228.46B
Novartis AG 211.63B
AstraZeneca 210.34B
Market Cap Rankings